{
    "Trade/Device Name(s)": [
        "On Call Sure Blood Glucose Monitoring System",
        "On Call Sure Sync Blood Glucose Monitoring System"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K181527",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130284"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "October 3, 2018",
    "Summary Letter Received Date": "August 31, 2018",
    "Submission Date": "October 1, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "On Call Sure Blood Glucose Meter",
        "On Call Sure Sync Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for On Call Sure and On Call Sure Sync Blood Glucose Monitoring Systems for quantitative glucose measurement in capillary whole blood using electrochemical detection.",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, and palm as an aid to monitor diabetes control; for single-patient use, not for diagnosis or screening of diabetes or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}